000538 云南白药
已收盘 04-18 15:00:00
资讯
新帖
简况
云南白药获得发明专利授权：“一种可拆卸生发仪”
证券之星 · 02-28
云南白药获得发明专利授权：“一种可拆卸生发仪”
中证全指医药卫生行业指数上涨0.34%，前十大权重包含云南白药等
金融界 · 02-27
中证全指医药卫生行业指数上涨0.34%，前十大权重包含云南白药等
2月24日云南白药发生1笔大宗交易 成交金额448.46万元
证券之星 · 02-24
2月24日云南白药发生1笔大宗交易 成交金额448.46万元
云南白药：公司采之汲球药隔重楼舒缓精华液有1.2ml次抛包装，便于携带
证券之星 · 02-21
云南白药：公司采之汲球药隔重楼舒缓精华液有1.2ml次抛包装，便于携带
【云南白药集团上线DeepSeek大模型】 据云南白药消息，云南白药集团于2025年2月9日，结合工作实际，上线国产开源大模型 DeepSeek，依托企业级数字员工“白小柒”、“重小楼”及协同平台“白药钉”，加速中医药产业数字化升级。DeepSeek凭借行业领先的推理能力、完整的思维逻辑、卓越的模型性能以及多领域技术验证，为企业实现AI大模型全场景深度赋能。
金融界 · 02-12
【云南白药集团上线DeepSeek大模型】 据云南白药消息，云南白药集团于2025年2月9日，结合工作实际，上线国产开源大模型 DeepSeek，依托企业级数字员工“白小柒”、“重小楼”及协同平台“白药钉”，加速中医药产业数字化升级。DeepSeek凭借行业领先的推理能力、完整的思维逻辑、卓越的模型性能以及多领域技术验证，为企业实现AI大模型全场景深度赋能。
云南白药集团上线DeepSeek大模型
美港电讯 · 02-12
云南白药集团上线DeepSeek大模型
为上市公司市值管理提供全流程一站式综合金融服务——红塔证券助力云南省国有股权运营管理有限公司完成云南白药股份增持
红塔证券 · 02-11
为上市公司市值管理提供全流程一站式综合金融服务——红塔证券助力云南省国有股权运营管理有限公司完成云南白药股份增持
云南白药(000538.SZ)第一大股东国有股权管理公司共增持1780.75万股
智通财经 · 02-06
云南白药(000538.SZ)第一大股东国有股权管理公司共增持1780.75万股
2月6日云南白药发布公告，股东增持32.16万股
证券之星 · 02-06
2月6日云南白药发布公告，股东增持32.16万股
【云南白药：股东增持计划期限届满 累计增持1780.75万股】金融界2月6日消息，云南白药公告称，公司第一大股东云南省国有股权运营管理有限公司于2024年8月6日至2025年2月5日，通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份1780.75万股，占公司总股本的比例为0.9980%，累计增持金额为人民币9.5亿元。截至公告披露日，增持计划期限届满，本次增持计划已实施完成。
金融界 · 02-06
【云南白药：股东增持计划期限届满 累计增持1780.75万股】金融界2月6日消息，云南白药公告称，公司第一大股东云南省国有股权运营管理有限公司于2024年8月6日至2025年2月5日，通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份1780.75万股，占公司总股本的比例为0.9980%，累计增持金额为人民币9.5亿元。截至公告披露日，增持计划期限届满，本次增持计划已实施完成。
云南白药最新公告：高级管理人员到龄退休
证券之星 · 01-27
云南白药最新公告：高级管理人员到龄退休
云南白药(000538.SZ)首席创新官秦皖民退休请辞
智通财经 · 01-27
云南白药(000538.SZ)首席创新官秦皖民退休请辞
云南白药：公司深耕品牌建设，高度重视维护自身品牌权益
证券之星 · 01-27
云南白药：公司深耕品牌建设，高度重视维护自身品牌权益
云南白药：公司其他应收款相关信息请参见定期报告财务报告部分
金融界 · 01-27
云南白药：公司其他应收款相关信息请参见定期报告财务报告部分
云南白药：云南省医药有限公司持续巩固云南省药品流通市场份额
金融界 · 01-27
云南白药：云南省医药有限公司持续巩固云南省药品流通市场份额
云南白药（000538）股东云南省国有股权运营管理有限公司质押6750万股，占总股本3.78%
证券之星 · 01-24
云南白药（000538）股东云南省国有股权运营管理有限公司质押6750万股，占总股本3.78%
云南白药：1月23日接受机构调研，太平洋证券、深圳财沣投资等多家机构参与
证券之星 · 01-24
云南白药：1月23日接受机构调研，太平洋证券、深圳财沣投资等多家机构参与
云南白药（000538）股东云南省国有股权运营管理有限公司质押4800万股，占总股本2.69%
证券之星 · 01-17
云南白药（000538）股东云南省国有股权运营管理有限公司质押4800万股，占总股本2.69%
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。公司荣登BrandFinance发布的《全球最具价值与最强医药、医疗器械及医疗服务品牌价值排行榜》25强，美国《制药经理人》杂志公布的《全球制药企业50强排行榜》第33位，Interbrand发布的《中国最佳品牌排行榜》第45位，《凯度BrandZ最具价值中国品牌100强》排行榜第71位，医疗保健行业第1位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":57.45,"timestamp":1744959789000,"preClose":57.33,"halted":0,"volume":4371029,"delay":0,"changeRate":0.0021,"floatShares":1773000000,"shares":1784000000,"eps":3.0293,"marketStatus":"已收盘","change":0.12,"latestTime":"04-18 15:00:00","open":57.29,"high":57.56,"low":57.19,"amount":251000000,"amplitude":0.0065,"askPrice":57.45,"askSize":27,"bidPrice":57.44,"bidSize":2,"shortable":0,"etf":0,"ttmEps":3.0293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745199000000},"marketStatusCode":5,"adr":0,"adjPreClose":57.33,"symbolType":"stock","openAndCloseTimeList":[[1744939800000,1744947000000],[1744952400000,1744959600000]],"highLimit":63.06,"lowLimit":51.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":18.964777,"roe":"11.99%","epsLYR":2.66,"committee":-0.646018,"marketValue":102506000000,"turnoverRate":0.0025,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-04-22。","floatMarketCap":101841000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2516058763","title":"云南白药获得发明专利授权：“一种可拆卸生发仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2516058763","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516058763?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:25","pubTimestamp":1740770737,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示云南白药新获得一项发明专利授权，专利名为“一种可拆卸生发仪”，专利申请号为CN202411187728.X，授权日为2025年2月28日。今年以来云南白药新获得专利授权5个，较去年同期增加了25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030100008783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0196","BK0028","BK0175","BK0012","BK0188","BK0239","BK0187","BK0164"],"gpt_icon":0},{"id":"2514800619","title":"中证全指医药卫生行业指数上涨0.34%，前十大权重包含云南白药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2514800619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514800619?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:48","pubTimestamp":1740664127,"startTime":"0","endTime":"0","summary":"数据统计显示，中证全指医药卫生行业指数近一个月上涨6.70%，近三个月下跌0.34%，年至今上涨2.65%。从中证全指医药卫生行业指数持仓样本的行业来看，医药卫生占比100.00%。在样本公司有特殊事件发生，导致其行业归属发生变更时，将对中证全指行业指数样本进行相应调整。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/27214848438243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0164","BK0196","BK0187","BK0012","BK0239","BK0188","000538","BK0028","BK0175","000985.SH"],"gpt_icon":0},{"id":"2513710963","title":"2月24日云南白药发生1笔大宗交易 成交金额448.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513710963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513710963?lang=zh_cn&edition=full","pubTime":"2025-02-24 17:07","pubTimestamp":1740388049,"startTime":"0","endTime":"0","summary":"证券之星消息，2月24日云南白药发生大宗交易，交易数据如下：大宗交易成交价格55.64元，成交8.06万股，成交金额448.46万元，买方营业部为华泰证券股份有限公司深圳前海证券营业部，卖方营业部为华泰证券股份有限公司深圳前海证券营业部。近三个月该股共发生9笔大宗交易，合计成交1.12万手，折价成交6笔。该股近期无解禁股上市。截至2025年2月24日收盘，云南白药报收于55.64元，下跌0.59%，换手率0.53%，成交量9.32万手，成交额5.2亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022400022115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0175","BK0028","BK0012","BK0187","BK0188","000538","BK0164","BK0239"],"gpt_icon":0},{"id":"2513250530","title":"云南白药：公司采之汲球药隔重楼舒缓精华液有1.2ml次抛包装，便于携带","url":"https://stock-news.laohu8.com/highlight/detail?id=2513250530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513250530?lang=zh_cn&edition=full","pubTime":"2025-02-21 18:00","pubTimestamp":1740132050,"startTime":"0","endTime":"0","summary":"贵公司采之汲瓶子太大太重，不好携带建议瓶子小点，出一款纯植物提取面霜，不要添加任何化学物质针对高端人群。还有普洱茶建议出小包装试喝或者售卖，普洱茶市场本来就饱和状态，如果规格都是一饼，如果是我就情愿买喝过的或者熟悉品牌，或者给股东都发点。公司采之汲球药隔重楼舒缓精华液有1.2ml次抛包装，便于携带；醉春秋龙珠普洱茶，手工团茶成珠，外观松紧适度，色泽果绿油润，外形区别于您所提及的饼茶。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100032944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0012","BK0188","BK0175","BK0164","BK0187","000538","BK0239"],"gpt_icon":0},{"id":"2510324014","title":"【云南白药集团上线DeepSeek大模型】 据云南白药消息，云南白药集团于2025年2月9日，结合工作实际，上线国产开源大模型 DeepSeek，依托企业级数字员工“白小柒”、“重小楼”及协同平台“白药钉”，加速中医药产业数字化升级。DeepSeek凭借行业领先的推理能力、完整的思维逻辑、卓越的模型性能以及多领域技术验证，为企业实现AI大模型全场景深度赋能。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510324014","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510324014?lang=zh_cn&edition=full","pubTime":"2025-02-12 18:53","pubTimestamp":1739357582,"startTime":"0","endTime":"0","summary":"据云南白药消息，云南白药集团于2025年2月9日，结合工作实际，上线国产开源大模型 DeepSeek，依托企业级数字员工“白小柒”、“重小楼”及协同平台“白药钉”，加速中医药产业数字化升级。DeepSeek凭借行业领先的推理能力、完整的思维逻辑、卓越的模型性能以及多领域技术验证，为企业实现AI大模型全场景深度赋能。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12185348117673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000538"],"gpt_icon":0},{"id":"2510249933","title":"云南白药集团上线DeepSeek大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2510249933","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510249933?lang=zh_cn&edition=full","pubTime":"2025-02-12 18:51","pubTimestamp":1739357477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0012","BK0187","BK0188","BK0239","000538","BK0175","BK0028","BK0164","BK0196"],"gpt_icon":0},{"id":"2510826168","title":"为上市公司市值管理提供全流程一站式综合金融服务——红塔证券助力云南省国有股权运营管理有限公司完成云南白药股份增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2510826168","media":"红塔证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510826168?lang=zh_cn&edition=full","pubTime":"2025-02-11 09:13","pubTimestamp":1739236430,"startTime":"0","endTime":"0","summary":"红塔证券作为国有股权管理公司的财务顾问，通过投行团队+财富管理团队为本次增持从方案设计、合规论证、协助进行监管机构沟通及上市公司信息披露、交易实施等方面提供了全流程一站式综合金融服务，协助国有股权管理公司高质量完成了股份增持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211124326a24164ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211124326a24164ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","601236","BK0196","BK0028","BK0239","BK0276","BK0187","BK0164","BK0188","000538","BK0175"],"gpt_icon":0},{"id":"2509222699","title":"云南白药(000538.SZ)第一大股东国有股权管理公司共增持1780.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509222699","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509222699?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:02","pubTimestamp":1738839752,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云南白药(000538.SZ)发布公告，2024年8月6日至2025年2月5日，公司第一大股东国有股权管理公司通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份1780.75万股，增持数量占公司总股本的0.9980%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1246740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538","BK0187","BK0028","BK0164","BK0239","BK0175","BK0012","BK0196","BK0188"],"gpt_icon":0},{"id":"2509226262","title":"2月6日云南白药发布公告，股东增持32.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509226262","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509226262?lang=zh_cn&edition=full","pubTime":"2025-02-06 19:01","pubTimestamp":1738839681,"startTime":"0","endTime":"0","summary":"证券之星消息，2月6日云南白药发布公告《云南白药:关于股东增持计划期限届满暨实施完成的公告》，其股东云南省国有股权运营管理有限公司于2024年11月7日至2025年2月5日间合计增持32.16万股，占公司目前总股本的0.018%，变动期间该股股价下跌0.03%，截止2月5日收盘报57.42元。股东增减持详情见下表：根据云南白药2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020600032200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0196","BK0175","BK0012","000538","BK0188","BK0028","BK0239","BK0164"],"gpt_icon":0},{"id":"2509226336","title":"【云南白药：股东增持计划期限届满 累计增持1780.75万股】金融界2月6日消息，云南白药公告称，公司第一大股东云南省国有股权运营管理有限公司于2024年8月6日至2025年2月5日，通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份1780.75万股，占公司总股本的比例为0.9980%，累计增持金额为人民币9.5亿元。截至公告披露日，增持计划期限届满，本次增持计划已实施完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509226336","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509226336?lang=zh_cn&edition=full","pubTime":"2025-02-06 18:50","pubTimestamp":1738839043,"startTime":"0","endTime":"0","summary":"金融界2月6日消息，云南白药公告称，公司第一大股东云南省国有股权运营管理有限公司于2024年8月6日至2025年2月5日，通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份1780.75万股，占公司总股本的比例为0.9980%，累计增持金额为人民币9.5亿元。截至公告披露日，增持计划期限届满，本次增持计划已实施完成。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/06185047991150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0175","BK0012","000538","BK0239","399001","BK0028","BK0188","BK0187","BK0164","BK0196"],"gpt_icon":0},{"id":"2506373928","title":"云南白药最新公告：高级管理人员到龄退休","url":"https://stock-news.laohu8.com/highlight/detail?id=2506373928","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506373928?lang=zh_cn&edition=full","pubTime":"2025-01-27 19:30","pubTimestamp":1737977451,"startTime":"0","endTime":"0","summary":"云南白药公告，公司首席创新官、高级副总裁秦皖民和首席合规官、高级副总裁杨勇因已达到法定退休年龄，申请辞去公司相关职务以及在公司及其控股子公司的一切职务。根据《公司法》和《公司章程》的相关规定，秦皖民和杨勇的申请自送达董事会之日起生效。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700026803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0028","BK0239","BK0012","BK0187","BK0175","BK0164","000538"],"gpt_icon":0},{"id":"2506378053","title":"云南白药(000538.SZ)首席创新官秦皖民退休请辞","url":"https://stock-news.laohu8.com/highlight/detail?id=2506378053","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506378053?lang=zh_cn&edition=full","pubTime":"2025-01-27 19:23","pubTimestamp":1737976985,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云南白药(000538.SZ)公告，公司董事会于近日分别收到公司首席创新官、高级副总裁秦皖民先生以及首席合规官、高级副总裁杨勇先生送达的书面申请：秦皖民先生因已达到法定退休年龄，申请辞去公司首席创新官、高级副总裁以及在公司及其控股子公司的一切职务;杨勇先生因已达到法定退休年龄，申请辞去公司首席合规官、高级副总裁以及在公司及其控股子公司的一切职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","BK0028","BK0188","BK0164","BK0196","BK0012","BK0239","BK0187","000538"],"gpt_icon":0},{"id":"2506531196","title":"云南白药：公司深耕品牌建设，高度重视维护自身品牌权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2506531196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506531196?lang=zh_cn&edition=full","pubTime":"2025-01-27 11:00","pubTimestamp":1737946809,"startTime":"0","endTime":"0","summary":"公司深耕品牌建设，高度重视维护自身品牌权益，我司品牌维权电话是0871-66225010，欢迎您对相关问题进行反馈，协助我公司收集维权线索。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700008028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0187","BK0239","BK0028","BK0196","000538","BK0188","BK0175","BK0012"],"gpt_icon":0},{"id":"2506339050","title":"云南白药：公司其他应收款相关信息请参见定期报告财务报告部分","url":"https://stock-news.laohu8.com/highlight/detail?id=2506339050","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506339050?lang=zh_cn&edition=full","pubTime":"2025-01-27 09:09","pubTimestamp":1737940185,"startTime":"0","endTime":"0","summary":"金融界1月27日消息，有投资者在互动平台向云南白药提问：公司其他应收款中 大量保证金与押金全额计提坏账无法收回的原因是什么？准备才去什么措施收回呢？公司回答表示：公司其他应收款相关信息请您参见定期报告第十节财务报告-五、重要会计政策及会计估计-11、金融工具-（8）金融资产减值中“d.其他应收款”部分内容。\n\n\r\n 责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/27090947833419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0012","BK0175","000538","BK0196","BK0187","BK0028","BK0164","BK0188"],"gpt_icon":0},{"id":"2506439066","title":"云南白药：云南省医药有限公司持续巩固云南省药品流通市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2506439066","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506439066?lang=zh_cn&edition=full","pubTime":"2025-01-27 09:02","pubTimestamp":1737939753,"startTime":"0","endTime":"0","summary":"公司回答表示：云南省医药有限公司是云南白药集团的全资子公司，前身为创建于1951年的云南省医药公司，是一家具有70余年历史的大型医药流通企业。云南省医药有限公司持续巩固云南省药品流通企业市场份额领先地位，已实现云南省16个州市全覆盖，渠道全面辐射各大零售连锁药店，协助政府、医疗机构搭建更好的管理及服务体系，为上下游客户提供优质的现代医药供应链服务解决方案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/27090247833422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0196","BK0187","159938","BK0175","BK1515","BK1574","BK0164","09939","BK0012","BK0028","BK0188","BK1161","000538","BK0239"],"gpt_icon":0},{"id":"2505850337","title":"云南白药（000538）股东云南省国有股权运营管理有限公司质押6750万股，占总股本3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505850337","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505850337?lang=zh_cn&edition=full","pubTime":"2025-01-24 21:24","pubTimestamp":1737725051,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药1月24日公开信息显示，股东云南省国有股权运营管理有限公司向渤海国际信托股份有限公司合计质押6750.0万股，占总股本3.78%。质押详情见下表：截止本公告日，股东云南省国有股权运营管理有限公司已累计质押股份1.16亿股，占其持股总数的24.73%。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400052013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0012","BK0188","BK0175","BK0164","BK0187","000538","BK0239"],"gpt_icon":0},{"id":"2505858581","title":"云南白药：1月23日接受机构调研，太平洋证券、深圳财沣投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2505858581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505858581?lang=zh_cn&edition=full","pubTime":"2025-01-24 19:02","pubTimestamp":1737716521,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年1月24日云南白药发布公告称公司于2025年1月23日接受机构调研，太平洋证券邱华颖、深圳财沣投资秦小茹、湖北盛世科技魏泽旺、吴国民,谢秀香,林楠,刘洋漾,许松,何建刚、宁波知远杨桑、蓝马资本韩圣洁、广州图灵周书冬、泽源太空融投资张柘豪、深圳斯比亚李双凤、广州顺从投资邱曙、上海谦璞投资陈实、杭州中众翟淋璐参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400044253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0187","BK0188","BK0239","BK0276","161027","BK0028","BK0012","BK0196","BK0175","BK0201","BK0077","601099","BK0183","000538"],"gpt_icon":0},{"id":"2504285165","title":"云南白药（000538）股东云南省国有股权运营管理有限公司质押4800万股，占总股本2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504285165","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504285165?lang=zh_cn&edition=full","pubTime":"2025-01-17 21:48","pubTimestamp":1737121700,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药1月17日公开信息显示，股东云南省国有股权运营管理有限公司向渤海国际信托股份有限公司合计质押4800.0万股，占总股本2.69%。质押详情见下表：截止本公告日，股东云南省国有股权运营管理有限公司已累计质押股份1.15亿股，占其持股总数的24.66%。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011700045045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0164","BK0187","BK0012","BK0175","000538","BK0188","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745142384916,"stockEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.037},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0368},{"period":"1year","weight":0.0878},{"period":"ytd","weight":-0.0417}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0437},{"period":"3month","weight":0.0108},{"period":"6month","weight":0.0047},{"period":"1year","weight":0.0659},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"167861人(较上一季度增加3.53%)","perCapita":"10560股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。公司荣登BrandFinance发布的《全球最具价值与最强医药、医疗器械及医疗服务品牌价值排行榜》25强，美国《制药经理人》杂志公布的《全球制药企业50强排行榜》第33位，Interbrand发布的《中国最佳品牌排行榜》第45位，《凯度BrandZ最具价值中国品牌100强》排行榜第71位，医疗保健行业第1位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}